Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
INTERVENTIONAL
1997-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Correlates of Substance Abuse - 11
NCT00000346
Prepulse Inhibition of Startle in Cocaine Dependence - 7
NCT00015249
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275
Treatment Outcome in CBT for Cocaine Use
NCT03538548
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amantadine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York MDRU
OTHER
National Institute on Drug Abuse (NIDA)
NIH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Rotrosen, M.D.
Role: PRINCIPAL_INVESTIGATOR
New York MDRU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York MDRU
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
NIDA Research Monograph Series 179, 1998 CPDD 98, 99.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Y01-5-0013-6
Identifier Type: -
Identifier Source: secondary_id
NIDA-5-0013-6
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.